Table 3 Prevalence of macrolide resistance and genotyping in M.pneumoniae clinical isolates in China
Area | Year | Macrolide resistance rate (No. of resistant isolate/total isolate) | Type 1 macrolide resistance rate (No. of type 1 resistant isolate/total type 1 isolate) | Type 2 macrolide resistance rate (No. of type 2 resistant isolate/total type2 isolate) | References |
|---|---|---|---|---|---|
China a (Beijing, Shanghai) | 2008–2011 | 86.0% (351/408) | 91.8% (345/376) | 15.6% (5/32) | See below |
 Beijing, China | 2008–2009 | 68.7% (46/67) | 78.0% (46/59) | 0% (0/8) | [22] |
 Shanghai, China | 2008–2009 | 90.0% (90/100) | 95.7% (89/93) | 14.3 (1/7) | [46] |
 Beijing, China | 2011 | 95.0% (38/40) | 95.0% (38/40) | NA | [43] |
 Beijing, China | 2008–2011 | 88.1% (177/201) | 93.5% (172/184) | 23.5% (4/17) | [24] |
China (Beijing) | 2014–2016 | 65.4% (53/81) | 95.7% (45/47) | 23.5% (8/34) | This study |